Cynthia Cetani
Compliance Officer presso INDIVIOR PLC
Patrimonio netto: 7 M $ in data 29/02/2024
Profilo
Currently, Cynthia Cetani is Chief Compliance & Integrity Officer at Indivior PLC.
She previously held the position of Head-Compliance Operations & Group Integrity at Novartis AG and Chief Compliance Officer for Novartis Pharmaceuticals Corp.
(a subsidiary of Novartis AG).
She received a graduate degree from Rider University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
INDIVIOR PLC
0.14% | 01/03/2024 | 187 810 ( 0.14% ) | 4 M $ | 29/02/2024 |
INDIVIOR PLC
0.09% | 14/03/2024 | 121 737 ( 0.09% ) | 3 M $ | 29/02/2024 |
Posizioni attive di Cynthia Cetani
Società | Posizione | Inizio |
---|---|---|
INDIVIOR PLC | Compliance Officer | 01/10/2018 |
Precedenti posizioni note di Cynthia Cetani
Società | Posizione | Fine |
---|---|---|
NOVARTIS AG | Compliance Officer | - |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Compliance Officer | - |
Formazione di Cynthia Cetani
Rider University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
INDIVIOR PLC | Health Technology |
NOVARTIS AG | Health Technology |
Aziende private | 1 |
---|---|
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |